142 related articles for article (PubMed ID: 37236832)
1. Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis.
Weinstein IC; Wu X; Hill A; Brennan D; Omil-Lima D; Basourakos S; Brant A; Lewicki P; Al Hussein Al Awamlh B; Spratt D; Bittencourt LK; Scherr D; Zaorsky NG; Nagar H; Hu J; Barbieri C; Ponsky L; Vickers AJ; Shoag JE
Eur Urol Oncol; 2023 Aug; 6(4):355-365. PubMed ID: 37236832
[TBL] [Abstract][Full Text] [Related]
2. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
[TBL] [Abstract][Full Text] [Related]
3. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Zattoni F; Marra G; Martini A; Kasivisvanathan V; Grummet J; Harkin T; Ploussard G; Olivier J; Chiu PK; Valerio M; Marquis A; Gontero P; Guo H; Zhuang J; Frydenberg M; Moon D; Morlacco A; Kretschmer A; Barletta F; Heidegger I; Tilki D; van den Bergh R; Dal Moro F; Briganti A; Montorsi F; Novara G; Gandaglia G;
Eur Urol Focus; 2023 Jul; 9(4):621-628. PubMed ID: 36746729
[TBL] [Abstract][Full Text] [Related]
4. Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis.
Goel S; Shoag JE; Gross MD; Al Hussein Al Awamlh B; Robinson B; Khani F; Baltich Nelson B; Margolis DJ; Hu JC
Eur Urol Oncol; 2020 Feb; 3(1):10-20. PubMed ID: 31492650
[TBL] [Abstract][Full Text] [Related]
5. The role of perilesional and multiparametric resonance imaging-targeted biopsies to reduce the risk of upgrading at radical prostatectomy pathology: A retrospective monocentric study.
Diamand R; Hollans M; Lefebvre Y; Sirtaine N; Limani K; Hawaux E; Abou Zahr R; Mattlet A; Albisinni S; Roumeguère T; Peltier A
Urol Oncol; 2022 May; 40(5):192.e11-192.e17. PubMed ID: 35236622
[TBL] [Abstract][Full Text] [Related]
6. MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.
Ahdoot M; Wilbur AR; Reese SE; Lebastchi AH; Mehralivand S; Gomella PT; Bloom J; Gurram S; Siddiqui M; Pinsky P; Parnes H; Linehan WM; Merino M; Choyke PL; Shih JH; Turkbey B; Wood BJ; Pinto PA
N Engl J Med; 2020 Mar; 382(10):917-928. PubMed ID: 32130814
[TBL] [Abstract][Full Text] [Related]
7. Prostate magnetic resonance imaging-targeted biopsy global grade correlates better than highest grade with prostatectomy grade.
Ren J; Melamed J; Taneja SS; Wysock JS; Huang WC; Lepor H; Deng FM
Prostate; 2023 Mar; 83(4):323-330. PubMed ID: 36461793
[TBL] [Abstract][Full Text] [Related]
8. Biopsy-Integrated 3D Magnetic Resonance Imaging Modeling of Prostate Cancer and Its Application for Gleason Grade and Tumor Laterality Assessment.
Kim J; Lim B; Jeong IG; Ro JY; Go H; Cho YM; Park KJ
Arch Pathol Lab Med; 2023 Feb; 147(2):159-166. PubMed ID: 35512234
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of high-grade prostate cancer pattern on MRI-targeted biopsies: predictors for downgrading and importance of concomitant systematic biopsies.
Manceau C; Fromont-Hankard G; Beauval JB; Lesourd M; Almeras C; Bajeot AS; Gautier JR; Soulié M; Loison G; Salin A; Tollon C; Malavaud B; Roumiguié M; Ploussard G
World J Urol; 2021 Sep; 39(9):3315-3321. PubMed ID: 33609168
[TBL] [Abstract][Full Text] [Related]
10. Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance.
Shoag JE; Cai PY; Gross MD; Gaffney C; Li D; Mao J; Nowels M; Scherr DS; Sedrakyan A; Hu JC
Cancer; 2020 Jul; 126(13):2986-2990. PubMed ID: 32320063
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging targeted biopsy in biopsy-naïve patients and the risk of overtreatment in prostate cancer: a grading issue.
Jabbour T; Peltier A; Rocq L; Sirtaine N; Lefebvre Y; Bourgeno H; Baudewyns A; Roumeguère T; Diamand R
BJU Int; 2024 Apr; 133(4):432-441. PubMed ID: 37943114
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
Payrard-Starck C; Fourcade A; An Nguyen T; Tissot V; Doucet L; Marolleau J; Lucas C; Fournier G; Valeri A
Prog Urol; 2023 Apr; 33(5):265-271. PubMed ID: 36740508
[TBL] [Abstract][Full Text] [Related]
13. The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy.
Gaffney CD; Tin AL; Fainberg J; Fine S; Jibara G; Touijer K; Eastham J; Scardino P; Laudone V; Vickers AJ; Ehdaie B
Cancer; 2023 Dec; 129(23):3790-3796. PubMed ID: 37584213
[TBL] [Abstract][Full Text] [Related]
14. Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.
Diamand R; Peltier A; Roche JB; Lievore E; Lacetera V; Chiacchio G; Beatrici V; Mastroianni R; Simone G; Windisch O; Benamran D; Fourcade A; Nguyen TA; Fournier G; Fiard G; Ploussard G; Roumeguère T; Albisinni S
World J Urol; 2023 Jan; 41(1):77-84. PubMed ID: 36509932
[TBL] [Abstract][Full Text] [Related]
15. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?
Baboudjian M; Diamand R; Uleri A; Beauval JB; Touzani A; Roche JB; Lacetera V; Roumeguère T; Simone G; Benamran D; Fourcade A; Gondran-Tellier B; Fiard G; Peltier A; Ploussard G
Eur Urol; 2024 Mar; ():. PubMed ID: 38494379
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
17. The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology.
Sorce G; Stabile A; Pellegrino F; Mazzone E; Mattei A; Afferi L; Serni S; Minervini A; Roumiguiè M; Malavaud B; Valerio M; Rakauskas A; Marra G; Gontero P; Porpiglia F; Guo H; Zhuang J; Gandaglia G; Montorsi F; Briganti A
World J Urol; 2024 Apr; 42(1):248. PubMed ID: 38647689
[TBL] [Abstract][Full Text] [Related]
18. Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology.
Aslan G; Çelik S; Sözen S; Akdoğan B; İzol V; Yücel Bilen C; Sahin B; Türkeri L;
Int J Clin Pract; 2021 Mar; 75(3):e13797. PubMed ID: 33113261
[TBL] [Abstract][Full Text] [Related]
19. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis.
Drost FH; Osses D; Nieboer D; Bangma CH; Steyerberg EW; Roobol MJ; Schoots IG
Eur Urol; 2020 Jan; 77(1):78-94. PubMed ID: 31326219
[TBL] [Abstract][Full Text] [Related]
20. Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification.
Yu A; Yamany T; Mojtahed A; Hanna N; Nicaise E; Harisinghani M; Wu CL; Dahl DM; Wszolek M; Blute ML; Feldman AS
Urol Oncol; 2022 Feb; 40(2):59.e1-59.e5. PubMed ID: 34544650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]